Otros idiomas InDex Pharmaceuticals Holding AB

Acciones

INDEX

SE0008966295

Mercado cerrado - Nasdaq Stockholm Otros sitios de cotización 12:52:54 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,394 ^SEK	-1,50 %		+12,89 %	+53,91 %

26/04	InDex Pharmaceuticals Holding AB (publ) informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
05/04	Index Pharmaceuticals Holding AB (Publ) anuncia las dimisiones de su Junta Directiva	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

InDex Pharmaceuticals Holding AB (publ) interim report January - March 2024	26/04
InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
InDex Pharmaceuticals brings forward the publication of the interim report for Q1 2024	22/04
InDex Pharmaceuticals provides a company update	08/04
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2023	08/04
Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)	05/04
Index Pharmaceuticals Holding AB Announces Board Resignations	05/04
InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease	26/03
CEO and CFO both to leave InDex Pharmaceuticals	26/03
Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO	26/03
InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024	26/03
InDex Pharmaceuticals Holding AB Announce Resignation of Johan Giléus as CFO, Effective September 26, 2024	26/03
InDex Pharmaceuticals Launches Strategic Review Amid Decision to Stop Cobitolimod Development	27/02
InDex Pharmaceuticals provides an update on company's future	26/02
InDex Pharmaceuticals discontinues the development of cobitolimod	26/02
InDex Pharmaceuticals Holding AB Discontinues the Development of Cobitolimod	26/02
InDex Pharmaceuticals Holding AB (publ) year-end report 2023	21/02
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	21/02
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/02
InDex Pharmaceuticals announces expected cash balance per March 31, 2024	19/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas InDex Pharmaceuticals Holding AB

Acciones

INDEX

SE0008966295

Otros idiomas

Filtros